Fenofibrate/rosiglitazone interactionDecreased HDL cholesterol levels: 3 patients

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2008年 / 1223卷 / 1期
关键词：
Coronary Artery Disease; Aspirin; Warfarin; Metformin; Simvastatin;
D O I：
10.2165/00128415-200812230-00041
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：13 / 13
相关论文
共 50 条
  • [1] Fenofibrate plus rosiglitazone lowers HDL-cholesterol levels
    Reactions Weekly, 2004, 1019 (1) : 4 - 4
  • [2] Fenofibrate/rosiglitazone interactionParadoxical decrease in HDL cholesterol in elderly patients: 2 case reports
    Reactions Weekly, 2011, 1347 (1) : 21 - 21
  • [3] Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol
    Normén, L
    Frohlich, J
    Montaner, J
    Harris, M
    Elliott, T
    Bondy, G
    DIABETES CARE, 2004, 27 (09) : 2241 - 2242
  • [4] ROSIGLITAZONE AND FENOFIBRATE IMPROVE HDL METABOLISM ASSESSED BY FERHDL
    Dobiasova, M.
    Vrablik, M.
    Stulc, T.
    Dolezalova, R.
    Kasalova, Z.
    Zlatohlavek, L.
    Ceska, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 191 - 192
  • [5] Paradoxically decreased HDL-cholesterol levels associated with rosiglitazone therapy
    Gutschi, L. Maria
    Malcolm, Janine C.
    Favreau, Colette M.
    Ooi, Teik Chye
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (09) : 1672 - 1676
  • [6] HDL Cholesterol Reduction during Rosiglitazone and Fenofibrate Treatment in a Type 2 Diabetes Mellitus Patient with Dyslipidemia
    Im, Mijeong
    Kim, Minki
    Lee, Jin Kyung
    Chang, Yoon Hwan
    Lee, Dong Young
    Hong, Seok-Il
    Lee, Yun Yong
    Hong, Young Jun
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2010, 30 (01): : 17 - 19
  • [7] Reduced high-density lipoprotein cholesterol in patients receiving rosiglitazone and fenofibrate
    Venero, Carmelo V.
    Thompson, Paul D.
    Fernandez, Antonio B.
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (10): : E3 - E4
  • [8] HDL CHOLESTEROL AND THE RATIO OF HDL CHOLESTEROL TO TOTAL CHOLESTEROL LEVELS IN CLOFIBRATE TREATED HYPERLIPIDEMIC PATIENTS
    LEIGEL, Y
    YESHURUN, D
    ROSENSWEIG, B
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1983, 19 (01): : 104 - 104
  • [9] Fenofibrate paradoxically increases plasma total cholesterol levels but not HDL-cholesterol levels in apo E-KO mice
    Yeganeh, B
    Jolodar, A
    Mueller, C
    Hourihane, AGS
    Moghadasian, MH
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 293 - 294
  • [10] Fall in HDL-cholesterol in diabetic patients treated with micronised fenofibrate therapy
    Hulme, SA
    Furlong, NJ
    Obrien, SV
    Hardy, KJ
    DIABETES, 2002, 51 : A495 - A495
12345